Zevra Therapeutics (ZVRA) Change in Receivables (2019 - 2026)
Zevra Therapeutics' Change in Receivables came in at $5.74 million for Q2 2026, up 18.1% from $4.86 million a year earlier.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Change in Receivables (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Zevra Therapeutics reported Change in Receivables of $3.86 million, down 54.8% year-over-year; for FY2025, it was $11.98 million.
- Change in Receivables carries a five-year compound annual growth rate of 75.8% (FY2020 to FY2025).
- Going back by year, Change in Receivables was -$6.87 million in FY2024, $9.08 million in FY2023 (+34.1%), $6.77 million in FY2022 and -$1.05 million in FY2021.
- The five-year range for quarterly Change in Receivables is -$9.07 million (Q1 2024) to $7.45 million (Q4 2023).
- Year-over-year, Change in Receivables increased in three of the last four quarters, with growth averaging 186.5%.
- Business Quant data shows ZVRA's Change in Receivables at -$6.89 million (Q1 2026), $6.37 million (Q4 2025) and -$1.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.09 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 333.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 140.20 Mn |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | 5.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.74 Mn |
| Mar 31, 2026 | -6.89 Mn |
| Dec 31, 2025 | 6.37 Mn |
| Sep 30, 2025 | -1.36 Mn |
| Jun 30, 2025 | 4.86 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 2.72 Mn |
| Sep 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | 642,000.00 |
| Mar 31, 2024 | -9.07 Mn |
| Dec 31, 2023 | 7.45 Mn |
| Sep 30, 2023 | -4.11 Mn |
| Jun 30, 2023 | 6.21 Mn |
| Mar 31, 2023 | -477,000.00 |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 3.35 Mn |
| Jun 30, 2022 | -500,000.00 |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | -91,000.00 |
| Sep 30, 2021 | -269,000.00 |
API Access
Zevra Therapeutics Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();